DE602006016133D1 - Verwendung von stefin a als gerüstprotein - Google Patents

Verwendung von stefin a als gerüstprotein

Info

Publication number
DE602006016133D1
DE602006016133D1 DE602006016133T DE602006016133T DE602006016133D1 DE 602006016133 D1 DE602006016133 D1 DE 602006016133D1 DE 602006016133 T DE602006016133 T DE 602006016133T DE 602006016133 T DE602006016133 T DE 602006016133T DE 602006016133 D1 DE602006016133 D1 DE 602006016133D1
Authority
DE
Germany
Prior art keywords
stefin
scaffold
mutations
relates
leu73
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006016133T
Other languages
English (en)
Inventor
Robbie Woodman
Johannes Tsung-Han Yeh
Sophie Laurenson
Ferrigno Paul Ko
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medical Research Council
Original Assignee
Medical Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0511873A external-priority patent/GB0511873D0/en
Priority claimed from GB0608836A external-priority patent/GB0608836D0/en
Application filed by Medical Research Council filed Critical Medical Research Council
Publication of DE602006016133D1 publication Critical patent/DE602006016133D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/8139—Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1044—Preparation or screening of libraries displayed on scaffold proteins
DE602006016133T 2005-06-10 2006-06-08 Verwendung von stefin a als gerüstprotein Active DE602006016133D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0511873A GB0511873D0 (en) 2005-06-10 2005-06-10 Scaffold
GB0608836A GB0608836D0 (en) 2006-05-04 2006-05-04 Scaffold
PCT/GB2006/002115 WO2006131749A2 (en) 2005-06-10 2006-06-08 Scaffold

Publications (1)

Publication Number Publication Date
DE602006016133D1 true DE602006016133D1 (de) 2010-09-23

Family

ID=37314237

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006016133T Active DE602006016133D1 (de) 2005-06-10 2006-06-08 Verwendung von stefin a als gerüstprotein

Country Status (9)

Country Link
US (2) US8063019B2 (de)
EP (1) EP1904529B1 (de)
JP (1) JP4989638B2 (de)
AT (1) ATE477272T1 (de)
AU (1) AU2006256530B2 (de)
CA (1) CA2610976C (de)
DE (1) DE602006016133D1 (de)
DK (1) DK1904529T3 (de)
WO (1) WO2006131749A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2610976C (en) * 2005-06-10 2020-11-24 Robbie Woodman Use of stefin a as a scaffold protein
GB0807065D0 (en) 2008-04-18 2008-05-21 Univ Leeds Novel scaffolds
GB201302597D0 (en) 2013-02-14 2013-04-03 Univ Leeds Novel Synthetic Proteins
CN106573961B (zh) 2014-06-20 2022-01-04 豪夫迈·罗氏有限公司 基于chagasin的支架组合物、方法和应用
US20210206818A1 (en) 2016-01-22 2021-07-08 Modernatx, Inc. Messenger ribonucleic acids for the production of intracellular binding polypeptides and methods of use thereof
EP4112741A1 (de) 2017-01-04 2023-01-04 MGI Tech Co., Ltd. Schrittweise sequenzierung durch nichtmarkierte reversible terminatoren oder natürliche nukleotide
BR112019019630A2 (pt) 2017-05-19 2020-04-14 Philip Morris Products Sa teste diagnóstico para distinguir o status de tabagismo de um sujeito
GB201710973D0 (en) * 2017-07-07 2017-08-23 Avacta Life Sciences Ltd Scaffold proteins
US20230097573A1 (en) * 2019-10-16 2023-03-30 Lg Chem, Ltd. Neonatal fc receptor binding affimers
GB202101299D0 (en) 2020-06-09 2021-03-17 Avacta Life Sciences Ltd Diagnostic polypetides and methods
WO2023182945A2 (en) * 2022-03-24 2023-09-28 Agency For Science, Technology And Research Engineering peptides using peptide epitope linker evolution

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1231274A3 (de) * 1994-11-21 2002-10-09 The University Of Leeds Modifizierte Protease-Inhibitoren
DE69902924T2 (de) 1998-07-20 2003-05-28 Inoxell As Horsholm Neue methoden zum auffinden von liganden- und ziel-biomolekülen
WO2005046709A2 (en) * 2003-11-06 2005-05-26 Genencor International, Inc. Tgf - beta binding and supported peptides
CA2610976C (en) * 2005-06-10 2020-11-24 Robbie Woodman Use of stefin a as a scaffold protein

Also Published As

Publication number Publication date
DK1904529T3 (da) 2010-11-15
WO2006131749A3 (en) 2007-05-18
AU2006256530A1 (en) 2006-12-14
CA2610976C (en) 2020-11-24
WO2006131749A2 (en) 2006-12-14
EP1904529B1 (de) 2010-08-11
US20120190819A1 (en) 2012-07-26
US8481491B2 (en) 2013-07-09
JP4989638B2 (ja) 2012-08-01
CA2610976A1 (en) 2006-12-14
US8063019B2 (en) 2011-11-22
EP1904529A2 (de) 2008-04-02
US20080207509A1 (en) 2008-08-28
AU2006256530B2 (en) 2012-12-20
JP2008541776A (ja) 2008-11-27
ATE477272T1 (de) 2010-08-15

Similar Documents

Publication Publication Date Title
DE602006016133D1 (de) Verwendung von stefin a als gerüstprotein
ATE540111T1 (de) Hla-dr-bindendes antigenpeptid, das von wt1 abgeleitet ist
ATE546533T1 (de) Rekombinante expression von proteinen in einer disulfidverbrückten, zweikettigen form
GEP20105059B (en) Anti-cd154 antibodies
MX348154B (es) Anticuerpos de enlace a il-1-beta y fragmentos de los mismos.
DE602005020165D1 (de) Verfahren zur herstellung von l-arginin, l-ornithin oder l-citrullin
DE60035419D1 (de) Antigene peptide aus neisseria
DE50112802D1 (de) Peptide, deren herstellung und verwendung zur bindung von immunglobulinen
Claeys et al. Multiple gene duplication in the evolution of plasminogen. Five regions of sequence homology with the two internally homologous structures in prothrombin
IL173952A0 (en) Anti-angiogenic peptides and pharmaceutical compositions based thereon
ATE457352T1 (de) Subtilisin-carlsberg-proteine mit verminderter immunogenität
DE60335726D1 (de) Chromoprotein und fluoroproteine
WO2010007144A3 (en) Mutated netrin-4 proteins, fragments thereof and their uses as drugs
IL173954A0 (en) Libraries of recombinant chimeric proteins and methods of generating the same
WO2007013358A3 (en) Vivit polypeptides, therapeutic agent comprising the same, and method of screening for anti-cancer agent
DE60028248D1 (de) Methode zur reduzierung der immunogenizität von staphylokinase durch entfernen von t-zell epitopen
ATE466876T1 (de) Immunogene konstrukte
EP1499349A4 (de) Rekombinante hybrid-allergenkonstrukte mit verringerter allergenität unter beibehaltung der immunogenität des natürlichen allergens
ATE538806T1 (de) Peptide mit spezifischem sitz in herzgefässen und verwandte konjugate und verfahren
DK2186898T3 (da) Blomstrings-induktion
ATE423200T1 (de) Neues plexin-polypeptid, dieses codierende dna und verwendung davon
DE602004008081D1 (de) Verfahren zum spalten von proteinen
ATE529437T1 (de) Verfahren zur sauerstoff-regulierten produktion von recombinanter staphylokinase